Press Release Oncology Venture is issuing 2,255,639 shares under its convertible note agreement with Negma Group LTD and Park Partners GB

by NASDAQ Market News June 10, 2020

NASDAQ Market News
Click here to email author

Taconic Biosciences Expands Production of Critical Immunodeficient Model

RenovaCare Appoints Chief Medical Officer, Dr. Jo Ellen Schweinle, Former Sr. Medical Officer at U.S. Dept. of Health and Human Services

Ads